High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.

Aikaterini PapamanoliJeanwoo YooPrabhjot GrewalWilliam PredunJessica HotellingRobin JacobAzad MojahediHal A SkopickiMohamed MansourLuis A MarcosAndreas P Kalogeropoulos

Published in: European journal of clinical investigation (2020)

In nonintubated patients with severe COVID-19 pneumonia, methylprednisolone was associated with reduced need for mechanical ventilation and less-intensive care resource utilization without excess complications.

Keyphrases

high dose
mechanical ventilation
coronavirus disease
sars cov
respiratory failure
acute respiratory distress syndrome
stem cell transplantation
low dose
intensive care unit
respiratory syndrome coronavirus
community acquired pneumonia